Warby Parker (WRBY) Q1 2026 Earnings Transcript

Warby Parker reported Q1 revenue of $242.4 million, up 8.3% year over year, and adjusted EBITDA of $29.6 million, both ahead of guidance, while reaffirming full-year 2026 revenue guidance of $959 million to $976 million and adjusted EBITDA of $117 million to $119 million. Retail revenue rose 13.6%, eye exams grew 30%, and the company opened 14 net new stores, but adjusted gross margin fell 220 bps to 54.2% due to fixed-cost deleverage, tariffs, and higher lab/shipping costs. Management highlighted strengthening insurance penetration, improving non-Home Try-On e-commerce trends, and preparations for AI glasses and sport eyewear launches, with AI glasses revenue excluded from guidance.

Analysis

WRBY is transitioning from a pure unit-growth story to a mix-and-monetization story, and that matters more than the headline revenue beat. The key second-order effect is that store density plus exam penetration is creating a customer acquisition moat: exams increase conversion into glasses, while insurance plumbing reduces friction and should lift AOV without needing proportional marketing spend. That combination is why the business can absorb near-term gross margin pressure from labor, occupancy, and tariffs while still preserving EBITDA leverage.

The market is likely underestimating how much of the current guide depends on operational normalization rather than one-off demand. Weather and Home Try-On are masking underlying momentum, but the more important catalyst is that e-commerce is being rebuilt into a higher-intent channel via AI personalization, which should improve conversion even if traffic stays choppy. If that works, the street may need to revise not just revenue but the mix of digital orders toward higher-margin non-HTO purchases, which would mechanically improve gross profit per order over the next 2-3 quarters.

The AI glasses launch is the real option value, but it is also the biggest source of execution risk because it forces Warby into a different supply-chain and support model before product-market fit is proven. The Google reimbursement lowers capex-like burden, but it does not eliminate the risk that launch costs and service complexity outrun early demand. Consensus appears to be treating AI glasses as upside optionality; the more realistic base case is that the first 6-12 months will be a margin drag with uncertain conversion, so the stock should be valued on core eyewear compounding, not launch hype.

Key Decisions for Investors

• Long WRBY on weakness over the next 2-4 weeks: use the Q2 guide as a floor, with upside if non-HTO e-commerce and insurance penetration continue to inflect; risk/reward favors a tactical long while sentiment is still anchored to margin pressure.
• Pair trade: long WRBY / short a legacy optical or broad discretionary retailer basket over 3-6 months; WRBY has a cleaner path to AOV expansion and customer monetization, while peers remain more exposed to traffic softness and lack comparable insurance-driven conversion tools.
• Buy WRBY Jan-2027 calls or call spreads to express AI glasses optionality with limited downside; the launch is not in guidance, so even modest adoption could rerate the multiple, but the product risk argues for defined-risk structures.
• Short-term hedge: if long WRBY equity, pair with a small short in GOOGL only if you want to isolate launch-execution risk rather than platform upside; Google benefits from the partnership, but most of WRBY’s near-term value creation still depends on its own retail execution.
• Monitor for a better entry after any post-launch selloff in the next 6-9 months; if margins compress before AI glasses revenue appears, that would create a more attractive entry because the core business should still be compounding at high single-digit to low double-digit rates.